Led · Series B · Apr 2026

Founded in Barcelona in 2020 by Francesc Font, Bea Mesas and Joaquim Mach, Incapto operates a vertically integrated coffee-as-a-service model combining in-house roasting, connected hardware and a digital subscription platform. Its IoT-enabled machines send usage data back to the platform, which the company uses to optimise delivery timing, personalise selections across nine-plus origins, and automate reorders. Inventory is presold through subscriptions prior to roasting, and the service targets both households and office customers as an alternative to capsule systems. Incapto positions itself as a technology-enabled service company blending hardware, software and subscriptions, competing with both subscription coffee services (e.g., Pact Coffee, Trade Coffee, Bottomless) and premium machine makers (e.g., Nespresso, De'Longhi, Jura). The company has stated that the fresh-bean subscription model reduces capsule waste and can be more cost-effective than traditional capsule systems. Financially, the business has raised about €16 million to date, including the newly closed €10 million Series B.

Led · Series D · Nov 2025

San-Francisco-based The EVERY Company engineers highly functional egg proteins—such as OvoPro (ovalbumin) and OvoBoost—through precision fermentation instead of relying on chickens. Its shelf-stable, powder-format ingredients replicate or exceed the performance of traditional eggs, offering bakeries and other food producers a cage-free-compliant, 18-month-stable supply that sidesteps avian-flu and price-volatility risks. The firm is already selling metric tons of product each month at commercial scale and will see its proteins debut nationwide in Walmart-stocked products this month. Proceeds from its latest financing will expand manufacturing capacity and push the business toward profitability as it targets the $270 billion global egg market, with an initial focus on high-volume bakery customers. EVERY positions its biomanufacturing platform as a resilient, geographically flexible addition to the global protein supply chain. The company’s B2B model aims for mass-market adoption by supplying multinational food brands with drop-in egg alternatives. While revenue figures were not disclosed, management states that the business has moved from proof-of-concept to industrial-scale production.

Participated · Series D · Oct 2025

Ecorobotix is a Swiss B-Corporation that develops Plant-by-Plant™ artificial intelligence and ultra-high-precision (UHP) spraying systems for agriculture. Its vision is to transform crop protection by identifying and treating every individual plant with a spray footprint of only a few centimetres, dramatically reducing pesticide and crop-protection inputs while sustaining yields. The company’s flagship product, ARA, already runs more than 25 crop algorithms and is deployed in over 20 countries across Europe, the Americas and Oceania. Growers using the system can safely apply non-selective products, lower input costs, meet stricter regulations and achieve higher yields. Backed by strong investor support, Ecorobotix has raised $150 million across its Series C and Series D rounds, giving it the financial resources to scale. Management states the new capital will accelerate innovation, expand into additional crop types, broaden the product range and speed the release of new crop algorithms. The firm will unveil further advancements at the Agritechnica show in Hanover this November.

Participated · Series B · Feb 2024

Oishii operates large-scale indoor vertical Smart Farms that combine robotics, automation and Japanese farming techniques to grow pesticide-free, Non-GMO strawberries year-round. Founded in 2016, the company has expanded distribution across 18 U.S. states and launched retail in Toronto as its first international market. Oishii has broadened its product portfolio from ultra-premium Omakase Berries to the Koyo and Nikko Berry lines and introduced new pack sizes and formats with retail prices spanning roughly $4.99 to $15 and premium offerings at higher price points. The company has invested in automation and engineering capability, including the 2025 acquisition of Tortuga AgTech and a strategic partnership with MISUMI Group, and is developing an Open Innovation Center in Tokyo to advance R&D. Financially, Oishii has raised $370 million to date and is using new Series C proceeds to scale production, expand farm infrastructure, integrate more robotics, and develop new product formats.

Participated · Seed · Dec 2023

Clever Carnivore is a Chicago biotech startup developing low-cost, top-quality cultivated meat, currently producing cultivated pork sausage and planning a prototype Clever Bratwurst in early 2024. The company uses cell biology, recombinant protein technology and advanced bioreactor design to create sausages, burgers and chicken nuggets that compete on taste, price and convenience. R&D is led by co-founder Paul Burridge, Ph.D., and the team has optimized growth media to reduce cell culture media costs by one to two orders of magnitude versus other cultivated meat companies. Clever Carnivore emphasizes animal component-free media and superior cell growth performance to iterate production and formulation rapidly. The company is mission-driven to deliver cruelty-free, sustainable and cost-competitive meat alternatives to consumers. The business recently closed a $7M seed round that was oversubscribed and will fund expansion and scale-up efforts.